181 related articles for article (PubMed ID: 18593010)
1. Targeted therapies in cancer: myth or reality? Introduction.
Colotta F; Mantovani A
Adv Exp Med Biol; 2008; 610():v-vi. PubMed ID: 18593010
[No Abstract] [Full Text] [Related]
2. Anticancer drug discovery and development.
Colotta F
Adv Exp Med Biol; 2008; 610():19-42. PubMed ID: 18593013
[No Abstract] [Full Text] [Related]
3. X chemotherapy, myth and realities.
Thomas M; Pavithran K
J Indian Med Assoc; 2005 Sep; 103(9):489-90, 492, 494. PubMed ID: 16493871
[TBL] [Abstract][Full Text] [Related]
4. ESMO 2014: new trends in precision medicine.
Morere JF; Innominato P
Target Oncol; 2014 Dec; 9(4):293-4. PubMed ID: 25503266
[No Abstract] [Full Text] [Related]
5. Bringing science to cancer therapy.
Mellman I
Yale J Biol Med; 2006 Dec; 79(3-4):177-8. PubMed ID: 17940629
[No Abstract] [Full Text] [Related]
6. Clinical development of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors: what lessons have we learned?
Hidalgo M
Adv Exp Med Biol; 2008; 610():128-43. PubMed ID: 18593020
[No Abstract] [Full Text] [Related]
7. 2015 ASCO Annual Meeting.
Coburn C
Lancet Oncol; 2015 Jul; 16(7):755-6. PubMed ID: 26062778
[No Abstract] [Full Text] [Related]
8. Why I'm Holding onto Hope for Nano in Oncology.
Allen C
Mol Pharm; 2016 Aug; 13(8):2603-4. PubMed ID: 27404330
[No Abstract] [Full Text] [Related]
9. Making paediatric precision oncology a reality.
The Lancet Oncology
Lancet Oncol; 2016 Oct; 17(10):1335. PubMed ID: 27733256
[No Abstract] [Full Text] [Related]
10. Searching for the answer to cancer: new perspective may help to resolve an ageless conundrum.
Watson RA
Urol Oncol; 2013 Aug; 31(6):721-6. PubMed ID: 23769267
[No Abstract] [Full Text] [Related]
11. The evolution of the biomedical paradigm in oncology: implications for cancer therapy.
Corbellini G; Preti C
Adv Exp Med Biol; 2008; 610():5-18. PubMed ID: 18593012
[No Abstract] [Full Text] [Related]
12. [2015 through the eyes of the Bulletin of Cancer editorial board].
Magné N; Massard C; Bay JO; André T; Blay JY; Goncalves A; Orbach D; Wislez M; Thariat J; Penel N; Rancoule C; Vignot S
Bull Cancer; 2016 Jan; 103(1):3-17. PubMed ID: 26782079
[TBL] [Abstract][Full Text] [Related]
13. [Advances in medical oncology].
Shi YK
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):305-10. PubMed ID: 16900620
[TBL] [Abstract][Full Text] [Related]
14. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
15. Progress in Prostate Cancer (at Last!).
Glodé LM
Oncology (Williston Park); 2015 Jun; 29(6):407, 414. PubMed ID: 26091673
[No Abstract] [Full Text] [Related]
16. Triggering tumor immunity through angiogenesis targeting.
Jinushi M; Dranoff G
Clin Cancer Res; 2007 Jul; 13(13):3762-4. PubMed ID: 17606704
[No Abstract] [Full Text] [Related]
17. Targeting Biophysical Cues: a Niche Approach to Study, Diagnose, and Treat Cancer.
Zhang SX; Liu L; Zhao W
Trends Cancer; 2018 Apr; 4(4):268-271. PubMed ID: 29606309
[TBL] [Abstract][Full Text] [Related]
18. Cancer gene therapy based on the abstracts of the 2003 ASCO meeting and recent publications.
Ahmed CM
Drugs Today (Barc); 2004 Aug; 40(8):723-31. PubMed ID: 15510243
[TBL] [Abstract][Full Text] [Related]
19. Safety of Novel Targeted Therapies in Oncology.
Shah RR; Curigliano G
Drug Saf; 2019 Feb; 42(2):157-158. PubMed ID: 30649739
[No Abstract] [Full Text] [Related]
20. The future of oncology therapeutics.
Mansinho A; Boni V; de Miguel M; Calvo E
Expert Rev Anticancer Ther; 2017 Jul; 17(7):563-565. PubMed ID: 28504011
[No Abstract] [Full Text] [Related]
[Next] [New Search]
